C
Cirius Therapeutics
0 followers
Cirius Therapeutics is a clinical-stage company that develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis. The company developing MSDC-0602K, a next-generation insulin sensitizer for the treatment of nonalcoholic steatohepatitis (NASH). MSDC-0602K is currently being evaluat... Read more
Org chart
Bob Baltera
President & CEO
Board & advisors
Michael Jandernoa
Director
David Van Andel
Director
Robert L. Zerbe
Director
Jack Dixon
Scientific Advisor
Brian Finck
Scientific Advisor
Doug Morton
Scientific Advisor
Roger Ulrich
Scientific Advisor
Stephen A. Harrison
Scientific Advisor
Jorge Plutzky
Scientific Advisor
Daniel Bloomfield
Scientific Advisor